BACKGROUND AND OBJECTIVES: Adherence to daily asthma controller medication has been shown to be the most effective component of asthma self-management; however, patient's adherence to asthma medication remains poor. This study aimed to understand how patients' long-term asthma controller medication adherence may be improved and facilitated by comparing key asthma stakeholders' perspectives. METHOD: Six focus group interviews including 38 asthma stakeholders (n = 13 patients, n = 13 pulmonologist physicians, and n = 12 allied healthcare professionals) were conducted. Interviews were qualitatively analysed. RESULTS: Although similar themes were brought up across different asthma stakeholders, the way in which they were framed differed across stakeholders. The most salient discussion revolved around the content and the moment in which asthma education should be approached to facilitate patients' adherence to asthma medication. CONCLUSION: Asthma medication adherence is a complex process and successful interventions aimed at its improvement would benefit from: (a) making an effort to understand patients' experiences and negotiate the treatment regimen, rather than imposing recommendations; (b) considering treatment as a shared responsibility involving the patient, the healthcare professional(s), and the patients' social networks; and, (c) taking into account different stakeholders' concerns, needs, perspectives, and knowledge.
BACKGROUND AND OBJECTIVES: Adherence to daily asthma controller medication has been shown to be the most effective component of asthma self-management; however, patient's adherence to asthma medication remains poor. This study aimed to understand how patients' long-term asthma controller medication adherence may be improved and facilitated by comparing key asthma stakeholders' perspectives. METHOD: Six focus group interviews including 38 asthma stakeholders (n = 13 patients, n = 13 pulmonologist physicians, and n = 12 allied healthcare professionals) were conducted. Interviews were qualitatively analysed. RESULTS: Although similar themes were brought up across different asthma stakeholders, the way in which they were framed differed across stakeholders. The most salient discussion revolved around the content and the moment in which asthma education should be approached to facilitate patients' adherence to asthma medication. CONCLUSION: Asthma medication adherence is a complex process and successful interventions aimed at its improvement would benefit from: (a) making an effort to understand patients' experiences and negotiate the treatment regimen, rather than imposing recommendations; (b) considering treatment as a shared responsibility involving the patient, the healthcare professional(s), and the patients' social networks; and, (c) taking into account different stakeholders' concerns, needs, perspectives, and knowledge.
Entities:
Keywords:
Focus groups; education; facilitators; health care professionals; intervention; patients; physicians
Authors: Biagina-Carla Farnesi; Francine M Ducharme; Lucie Blais; Johanne Collin; Kim L Lavoie; Simon L Bacon; Martha L McKinney; Sandra Peláez Journal: Patient Prefer Adherence Date: 2019-04-23 Impact factor: 2.711
Authors: Amrit Bhatti; Karen Vinall-Collier; Raginie Duara; Jenny Owen; Kara A Gray-Burrows; Peter F Day Journal: BMC Oral Health Date: 2021-04-26 Impact factor: 2.757
Authors: Ping Yein Lee; Ai Theng Cheong; Sazlina Shariff Ghazali; Hani Salim; Jasmine Wong; Norita Hussein; Rizawati Ramli; Hilary Pinnock; Su May Liew; Nik Sherina Hanafi; Ahmad Ihsan Abu Bakar; Azainorsuzila Mohd Ahad; Yong Kek Pang; Karuthan Chinna; Ee Ming Khoo Journal: NPJ Prim Care Respir Med Date: 2021-07-07 Impact factor: 2.871
Authors: Thu-Anh Nguyen; Yen Ngoc Pham; Nhung Phuong Doan; Thao Huong Nguyen; Toan Thanh Do; Giap Van Vu; Guy B Marks; Shannon McKinn; Joel Negin; Sarah Bernays; Greg J Fox Journal: BMC Public Health Date: 2021-06-15 Impact factor: 3.295
Authors: Clare Miles; Emily Arden-Close; Mike Thomas; Anne Bruton; Lucy Yardley; Matthew Hankins; Sarah E Kirby Journal: NPJ Prim Care Respir Med Date: 2017-10-09 Impact factor: 2.871